The first Kaleido Biosciences trade was made in Q3 2019.
Since then Ken Griffin bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q1 2022 and Q2 2022.
Avg closing price
Price range
Sold -12.7 Thousand shares
Q2 2022
Avg closing price
$0.91
Price range
$0.17
-
$1.70
Sold 63.1% shares (-21.7 Thousand shares)
Q1 2022
Avg closing price
$1.78
Price range
$1.30
-
$2.70
Increased shares by 184.4% (+22.3 Thousand shares)
Q4 2021
Avg closing price
$4.07
Price range
$2.39
-
$6.02
Sold 60.4% shares (-18.4 Thousand shares)
Q3 2021
Avg closing price
$6.20
Price range
$5.36
-
$7.99
Increased shares by 63.6% (+11.8 Thousand shares)
Q2 2021
Avg closing price
$7.09
Price range
$5.82
-
$8.72
New holding (+18.6 Thousand shares)
Q1 2021
Avg closing price
$10.89
Price range
$7.20
-
$16.82
Sold -17.3 Thousand shares
Q2 2020
Avg closing price
$6.70
Price range
$4.62
-
$8.01
Sold 31.1% shares (-7.79 Thousand shares)
Q1 2020
Avg closing price
$6.53
Price range
$3.62
-
$9.49
Increased shares by 17.3% (+3.69 Thousand shares)
Q4 2019